(Q24299553)

English

Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells

scientific article

In more languages

Statements

scholarly article

0 references

Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells (English)

0 references

0 references

author name string

P Khanal

1

0 references

H J Yun

2

0 references

S C Lim

3

0 references

S G Ahn

4

0 references

H E Yoon

5

0 references

K W Kang

6

0 references

R Hong

7

0 references

H S Choi

8

0 references

language of work or name

0 references

publication date

23 August 2012

0 references

0 references

31

0 references

34

0 references

3845-56

0 references

Estrogen receptors and human disease

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

A human peptidyl-prolyl isomerase essential for regulation of mitosis

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

Pinning down proline-directed phosphorylation signaling

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

Molecular determinants for the tissue specificity of SERMs

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

Phosphorylation-specific prolyl isomerization: is there an underlying theme?

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

CDK-independent activation of estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1038/ONC.2011.548

20 April 2017

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

20 April 2017

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

20 April 2017

Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

20 April 2017

Endocrine-responsive breast cancer and strategies for combating resistance

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Regulation of Raf-1 by direct feedback phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Epigenetic information and estrogen receptor alpha expression in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Down-regulation of Raf-1 kinase is associated with paclitaxel resistance in human breast cancer MCF-7/Adr cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1).

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

21 January 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

31 March 2020

Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

31 March 2020

Animal cell cycles and their control

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.548

31 March 2020

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24299553&oldid=2175197241"